Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Steven Rosenberg

Concepts (596)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
57
2025
319
14.060
 Why?
Lymphocytes, Tumor-Infiltrating
62
2025
210
13.930
 Why?
Receptors, Antigen, T-Cell
55
2024
718
11.080
 Why?
Immunotherapy, Adoptive
53
2024
327
10.520
 Why?
T-Lymphocytes
47
2024
1996
7.340
 Why?
Melanoma
49
2024
760
7.150
 Why?
Neoplasms
35
2025
2671
5.430
 Why?
Gastrointestinal Neoplasms
8
2025
77
4.500
 Why?
CD8-Positive T-Lymphocytes
26
2023
900
3.890
 Why?
Autism Spectrum Disorder
22
2024
395
3.530
 Why?
Immunotherapy
16
2025
641
3.180
 Why?
Adoptive Transfer
18
2024
219
2.760
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
267
2.680
 Why?
Developmental Disabilities
13
2023
263
2.480
 Why?
Mutation
32
2025
3958
2.410
 Why?
Cancer Vaccines
8
2021
172
2.110
 Why?
Antigens, CD19
9
2022
123
2.060
 Why?
Programmed Cell Death 1 Receptor
9
2025
249
1.940
 Why?
CD4-Positive T-Lymphocytes
12
2022
1091
1.930
 Why?
Interleukin-2
7
2025
455
1.830
 Why?
Skin Neoplasms
13
2020
855
1.820
 Why?
Neoplasm Metastasis
18
2024
658
1.800
 Why?
Autistic Disorder
8
2024
204
1.740
 Why?
Humans
194
2025
137585
1.530
 Why?
ras Proteins
4
2021
153
1.440
 Why?
Colorectal Neoplasms
5
2025
806
1.390
 Why?
Neoplasm Proteins
7
2019
434
1.330
 Why?
Tumor Suppressor Protein p53
6
2022
528
1.270
 Why?
High-Throughput Nucleotide Sequencing
6
2025
539
1.240
 Why?
Eligibility Determination
3
2014
65
1.200
 Why?
Epitopes, T-Lymphocyte
9
2021
181
1.200
 Why?
Genetic Therapy
8
2022
297
1.170
 Why?
Lymphoma, B-Cell
4
2020
106
1.100
 Why?
Membrane Proteins
9
2019
1164
1.080
 Why?
Female
101
2025
73304
1.060
 Why?
Glioblastoma
2
2021
345
1.030
 Why?
Proto-Oncogene Proteins B-raf
4
2019
224
1.020
 Why?
Motor Skills Disorders
4
2016
28
1.000
 Why?
Child Development
7
2024
475
0.950
 Why?
Male
86
2025
67762
0.920
 Why?
Transcriptome
4
2022
971
0.900
 Why?
Middle Aged
56
2025
33479
0.900
 Why?
Genetic Engineering
6
2016
93
0.890
 Why?
HLA-A2 Antigen
11
2020
48
0.880
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
123
0.870
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1396
0.850
 Why?
Cell Line, Tumor
26
2021
3412
0.840
 Why?
Coronary Artery Disease
6
2017
698
0.820
 Why?
Flow Cytometry
9
2018
1178
0.810
 Why?
Precision Medicine
3
2015
429
0.800
 Why?
T-Lymphocyte Subsets
5
2019
417
0.780
 Why?
Ovarian Neoplasms
2
2019
565
0.770
 Why?
Tumor Microenvironment
2
2019
674
0.770
 Why?
Medicare Part C
2
2013
31
0.760
 Why?
Cell Separation
4
2019
318
0.740
 Why?
Adult
46
2025
37929
0.730
 Why?
Single-Cell Analysis
3
2022
313
0.730
 Why?
HLA-DP beta-Chains
3
2019
86
0.710
 Why?
Interleukin-12
3
2020
121
0.700
 Why?
Receptors, Antigen
3
2015
16
0.680
 Why?
Cognition Disorders
2
2016
496
0.670
 Why?
Aged
35
2025
23961
0.660
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
622
0.660
 Why?
HLA-A Antigens
2
2021
55
0.650
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
336
0.650
 Why?
Antigen Presentation
8
2020
218
0.640
 Why?
Retroviridae
2
2022
97
0.630
 Why?
Mutation, Missense
2
2020
341
0.630
 Why?
Interleukin-15
2
2017
98
0.630
 Why?
Colonic Neoplasms
2
2019
258
0.620
 Why?
Mucin-4
1
2019
4
0.620
 Why?
Smad5 Protein
1
2019
8
0.620
 Why?
Temperament
1
2019
46
0.610
 Why?
Exome
7
2016
231
0.610
 Why?
Lymphocyte Depletion
2
2016
135
0.600
 Why?
Immunity, Cellular
1
2020
268
0.600
 Why?
Child, Preschool
29
2024
11074
0.600
 Why?
T-Lymphocytes, Regulatory
2
2019
385
0.590
 Why?
Cholangiocarcinoma
2
2023
104
0.590
 Why?
Bile Duct Neoplasms
2
2023
124
0.580
 Why?
Sequence Analysis, DNA
2
2021
812
0.570
 Why?
ErbB Receptors
2
2019
614
0.570
 Why?
Disease Susceptibility
1
2019
347
0.540
 Why?
Genetic Vectors
5
2022
319
0.540
 Why?
Family Characteristics
2
2018
191
0.530
 Why?
Antigens
1
2019
357
0.530
 Why?
RNA, Messenger
3
2020
2833
0.520
 Why?
History, 20th Century
4
2025
325
0.520
 Why?
Child Behavior
1
2019
248
0.520
 Why?
Social Behavior
2
2023
287
0.510
 Why?
History, 21st Century
3
2025
213
0.510
 Why?
Myocardial Perfusion Imaging
2
2013
40
0.510
 Why?
Awards and Prizes
1
2017
67
0.500
 Why?
Communication
2
2023
879
0.500
 Why?
Transposases
1
2016
19
0.500
 Why?
Cell Engineering
1
2016
14
0.490
 Why?
Gene Expression Profiling
8
2019
1774
0.480
 Why?
Self-Injurious Behavior
4
2018
130
0.480
 Why?
Lymphoma
1
2017
208
0.480
 Why?
Psychotherapy
1
2017
167
0.480
 Why?
Cell Cycle Checkpoints
1
2016
98
0.480
 Why?
Bile Ducts, Intrahepatic
2
2023
78
0.480
 Why?
Immunologic Memory
5
2024
353
0.460
 Why?
Surveys and Questionnaires
9
2024
5778
0.440
 Why?
Breast Neoplasms
3
2022
2253
0.430
 Why?
T-Cell Antigen Receptor Specificity
7
2020
50
0.430
 Why?
Lymphocyte Transfusion
1
2013
21
0.420
 Why?
Lymphocytes
1
2016
397
0.420
 Why?
Lymphocyte Activation
10
2020
1142
0.420
 Why?
Sentinel Lymph Node Biopsy
1
2014
115
0.410
 Why?
Th1 Cells
1
2014
143
0.410
 Why?
Vidarabine
4
2017
33
0.410
 Why?
Indoles
1
2016
412
0.410
 Why?
Leukemia
2
2016
240
0.410
 Why?
Plaque, Atherosclerotic
1
2014
57
0.410
 Why?
Histocompatibility Antigens Class I
5
2021
203
0.400
 Why?
Animals
29
2024
36940
0.400
 Why?
Lymph Node Excision
1
2014
171
0.400
 Why?
Transplantation Conditioning
4
2019
170
0.390
 Why?
Sulfonamides
1
2016
513
0.390
 Why?
Child
22
2024
21935
0.390
 Why?
Cyclophosphamide
4
2017
247
0.390
 Why?
Melanoma, Experimental
4
2020
114
0.390
 Why?
Stem Cell Transplantation
1
2013
176
0.380
 Why?
Cell- and Tissue-Based Therapy
3
2019
81
0.380
 Why?
Transfection
1
2014
945
0.370
 Why?
Mice
21
2024
17787
0.370
 Why?
Genes, T-Cell Receptor
3
2022
9
0.370
 Why?
Gene Expression
7
2016
1502
0.370
 Why?
Antibodies, Monoclonal
3
2017
1430
0.360
 Why?
Melanoma-Specific Antigens
3
2016
5
0.350
 Why?
Adaptor Proteins, Signal Transducing
1
2014
430
0.350
 Why?
Biomarkers, Tumor
6
2019
1276
0.340
 Why?
Coronary Angiography
5
2017
317
0.340
 Why?
Neoplasms, Second Primary
2
2022
118
0.340
 Why?
Case-Control Studies
13
2024
3556
0.340
 Why?
Treatment Outcome
15
2021
10811
0.340
 Why?
United States
16
2025
14841
0.330
 Why?
Coculture Techniques
3
2021
239
0.330
 Why?
Transplantation, Autologous
3
2022
238
0.330
 Why?
Lung Neoplasms
3
2022
2526
0.330
 Why?
Receptor, ErbB-2
4
2016
341
0.330
 Why?
Papillomaviridae
3
2019
125
0.320
 Why?
gp100 Melanoma Antigen
5
2016
8
0.320
 Why?
Medicaid
1
2014
435
0.320
 Why?
Child Development Disorders, Pervasive
2
2024
62
0.320
 Why?
Papillomavirus Infections
3
2018
325
0.320
 Why?
Kidney Neoplasms
1
2014
403
0.320
 Why?
Infant
11
2017
9465
0.320
 Why?
Transduction, Genetic
4
2019
127
0.310
 Why?
Combined Modality Therapy
5
2021
1236
0.300
 Why?
Human papillomavirus 16
3
2018
35
0.300
 Why?
Peptides
4
2020
985
0.290
 Why?
Phenotype
6
2024
3196
0.290
 Why?
Prospective Studies
8
2023
7604
0.290
 Why?
Repressor Proteins
3
2017
427
0.280
 Why?
Intellectual Disability
3
2024
165
0.280
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
98
0.280
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
26
0.270
 Why?
Cells, Cultured
8
2021
4193
0.270
 Why?
Prevalence
8
2018
2734
0.270
 Why?
Algorithms
3
2015
1704
0.270
 Why?
Dendritic Cells
4
2019
483
0.260
 Why?
Neoplasm Staging
5
2018
1389
0.260
 Why?
Carcinoma, Squamous Cell
3
2017
683
0.260
 Why?
Oncogene Proteins, Viral
2
2017
22
0.260
 Why?
Lymphocyte Count
2
2016
148
0.250
 Why?
Tomography, X-Ray Computed
6
2018
2691
0.250
 Why?
Uterine Cervical Neoplasms
4
2018
257
0.250
 Why?
Cell Proliferation
8
2019
2475
0.250
 Why?
Young Adult
13
2020
13209
0.250
 Why?
CD8 Antigens
2
2018
75
0.250
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1692
0.250
 Why?
Antigens, CD
3
2020
521
0.250
 Why?
National Cancer Institute (U.S.)
1
2025
49
0.230
 Why?
Carcinoma
2
2018
240
0.230
 Why?
Pilot Projects
5
2019
1710
0.230
 Why?
Tumor Cells, Cultured
5
2018
955
0.230
 Why?
Whole-Body Irradiation
2
2016
78
0.230
 Why?
Brain Neoplasms
4
2018
1238
0.230
 Why?
Socioeconomic Factors
3
2018
1289
0.220
 Why?
DNA Transposable Elements
2
2016
121
0.220
 Why?
Longitudinal Studies
5
2016
2844
0.220
 Why?
T-Lymphocytes, Cytotoxic
2
2015
173
0.220
 Why?
Jaundice, Neonatal
1
2023
9
0.220
 Why?
Sensitivity and Specificity
3
2018
1946
0.210
 Why?
Adolescent
13
2023
21513
0.210
 Why?
Disability Evaluation
3
2014
290
0.210
 Why?
Immunohistochemistry
4
2016
1738
0.210
 Why?
Leukocytes, Mononuclear
3
2015
558
0.210
 Why?
Infant, Very Low Birth Weight
2
2014
68
0.210
 Why?
Protein Engineering
2
2014
97
0.200
 Why?
Problem Behavior
2
2022
102
0.200
 Why?
Parks, Recreational
1
2022
11
0.200
 Why?
Proto-Oncogene Proteins
2
2017
648
0.200
 Why?
Constriction, Pathologic
2
2014
245
0.190
 Why?
Time-to-Treatment
1
2024
205
0.190
 Why?
DNA-Binding Proteins
3
2019
1502
0.190
 Why?
Proteasome Endopeptidase Complex
2
2020
156
0.190
 Why?
Occupational Therapy
2
2014
100
0.190
 Why?
HEK293 Cells
5
2017
730
0.180
 Why?
Burkitt Lymphoma
1
2022
60
0.180
 Why?
Clone Cells
2
2019
265
0.180
 Why?
Amino Acid Sequence
4
2020
2139
0.180
 Why?
Sex Factors
4
2017
2071
0.180
 Why?
Adaptation, Psychological
2
2024
655
0.180
 Why?
Oncogenes
2
2020
116
0.180
 Why?
Biomarkers
3
2019
4149
0.180
 Why?
Genes, Tumor Suppressor
2
2019
86
0.180
 Why?
Exercise Test
2
2015
625
0.180
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.180
 Why?
Apyrase
1
2020
17
0.170
 Why?
Demography
3
2018
291
0.170
 Why?
Gene Expression Regulation
3
2019
2607
0.170
 Why?
Pancreatic Neoplasms
2
2022
938
0.170
 Why?
Lectins, C-Type
1
2020
67
0.170
 Why?
Cytokines
6
2022
2085
0.170
 Why?
Epitope Mapping
2
2018
62
0.170
 Why?
Multiple Myeloma
1
2023
252
0.170
 Why?
Oncolytic Virotherapy
1
2020
14
0.170
 Why?
MART-1 Antigen
3
2014
12
0.170
 Why?
HLA Antigens
2
2021
240
0.170
 Why?
Psychotropic Drugs
1
2021
68
0.170
 Why?
Physical Therapy Modalities
2
2014
308
0.170
 Why?
Mice, Mutant Strains
1
2020
298
0.170
 Why?
Models, Immunological
1
2020
100
0.160
 Why?
Lymphatic Metastasis
2
2019
352
0.160
 Why?
Drug Utilization
1
2021
169
0.160
 Why?
Premature Birth
1
2023
333
0.160
 Why?
HLA-C Antigens
2
2020
35
0.160
 Why?
Metastasectomy
2
2017
20
0.160
 Why?
Follow-Up Studies
7
2020
5131
0.160
 Why?
Protein Binding
8
2020
2224
0.160
 Why?
Virus Replication
1
2022
483
0.160
 Why?
Remission Induction
5
2020
288
0.160
 Why?
Amino Acid Substitution
1
2020
307
0.160
 Why?
Gene Regulatory Networks
1
2022
305
0.160
 Why?
Antibodies, Monoclonal, Humanized
1
2025
804
0.160
 Why?
Age Factors
3
2024
3295
0.150
 Why?
Genes, Neoplasm
1
2019
22
0.150
 Why?
Neoplasm Recurrence, Local
2
2017
1079
0.150
 Why?
Cysteine
1
2020
204
0.150
 Why?
Alcohol Oxidoreductases
1
2019
62
0.150
 Why?
Gestational Age
2
2024
910
0.150
 Why?
Practice Patterns, Physicians'
2
2021
1313
0.150
 Why?
Neoplasms, Glandular and Epithelial
1
2019
49
0.150
 Why?
Prognosis
6
2020
4030
0.150
 Why?
Area Under Curve
3
2014
314
0.150
 Why?
Cell Line
4
2022
2847
0.150
 Why?
Referral and Consultation
4
2023
786
0.150
 Why?
Neoplastic Cells, Circulating
1
2019
80
0.140
 Why?
Medical Oncology
1
2020
289
0.140
 Why?
Behavior Therapy
1
2021
264
0.140
 Why?
B-Lymphocytes
3
2020
847
0.140
 Why?
Cohort Studies
6
2016
5742
0.140
 Why?
Trees
1
2018
71
0.140
 Why?
RGS Proteins
1
2018
18
0.140
 Why?
Ubiquitin Thiolesterase
1
2018
48
0.140
 Why?
Mothers
1
2024
754
0.140
 Why?
Forkhead Transcription Factors
1
2019
191
0.140
 Why?
Education, Special
1
2017
23
0.140
 Why?
Parents
4
2022
1347
0.140
 Why?
Smoking
2
2018
1627
0.140
 Why?
Psychometrics
2
2019
720
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
87
0.140
 Why?
Uveal Neoplasms
1
2017
10
0.140
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
4
0.140
 Why?
Self-Examination
1
2017
2
0.130
 Why?
Hematologic Neoplasms
1
2019
156
0.130
 Why?
Recombinant Fusion Proteins
3
2015
665
0.130
 Why?
ROC Curve
3
2013
554
0.130
 Why?
Interferon-gamma
5
2020
789
0.130
 Why?
Societies, Scientific
1
2017
51
0.130
 Why?
Maternal Age
1
2017
129
0.130
 Why?
Signal Transduction
5
2019
5079
0.130
 Why?
Immunologic Surveillance
1
2017
25
0.130
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
171
0.130
 Why?
Administration, Intravenous
1
2017
155
0.130
 Why?
Carcinogenesis
1
2018
217
0.130
 Why?
Population Surveillance
2
2017
482
0.130
 Why?
fas Receptor
2
2015
95
0.130
 Why?
Disease Progression
5
2017
2757
0.130
 Why?
Tissue and Organ Procurement
1
2020
321
0.130
 Why?
CTLA-4 Antigen
1
2017
99
0.130
 Why?
Sialadenitis
1
2016
2
0.130
 Why?
WT1 Proteins
1
2016
15
0.130
 Why?
Peptidomimetics
1
2016
4
0.130
 Why?
Mitogen-Activated Protein Kinases
1
2017
313
0.130
 Why?
Circulating Tumor DNA
1
2016
34
0.130
 Why?
Green Fluorescent Proteins
2
2015
390
0.130
 Why?
Logistic Models
4
2016
2074
0.120
 Why?
Antineoplastic Agents
2
2017
2129
0.120
 Why?
HLA-DQ beta-Chains
1
2016
63
0.120
 Why?
Urinary Bladder Neoplasms
1
2019
252
0.120
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.120
 Why?
Transplantation Chimera
1
2016
54
0.120
 Why?
Immunoglobulin A
1
2017
211
0.120
 Why?
Immunodominant Epitopes
1
2015
27
0.120
 Why?
Clonal Evolution
1
2016
45
0.120
 Why?
Peer Group
1
2018
242
0.120
 Why?
Coronary Vessels
2
2017
248
0.120
 Why?
Immunoglobulin M
1
2017
289
0.120
 Why?
Molecular Targeted Therapy
1
2019
411
0.120
 Why?
Proto-Oncogene Proteins c-akt
2
2015
437
0.120
 Why?
Cesarean Section
1
2017
184
0.120
 Why?
Psychoanalytic Therapy
1
1995
10
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
137
0.120
 Why?
Aged, 80 and over
3
2025
7635
0.120
 Why?
RNA, Neoplasm
1
2015
82
0.120
 Why?
Receptors, HIV
1
2015
24
0.120
 Why?
Epitopes
2
2015
479
0.120
 Why?
Zinc Fingers
1
2015
50
0.120
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
73
0.120
 Why?
Psychotherapy, Brief
1
1995
34
0.120
 Why?
Immunophenotyping
1
2016
318
0.120
 Why?
Sarcoma, Synovial
1
2014
21
0.120
 Why?
Immunity, Active
1
2014
10
0.110
 Why?
Alphapapillomavirus
1
2015
39
0.110
 Why?
Odds Ratio
2
2014
1070
0.110
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
77
0.110
 Why?
Language
1
2018
292
0.110
 Why?
Psychotherapy, Group
1
1995
66
0.110
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.110
 Why?
Endoribonucleases
1
2015
81
0.110
 Why?
Metalloproteins
1
2014
6
0.110
 Why?
Aspirin
1
2018
387
0.110
 Why?
Managed Care Programs
1
1995
135
0.110
 Why?
Clinical Trials as Topic
5
2020
1050
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
76
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
202
0.110
 Why?
5' Untranslated Regions
1
2014
58
0.110
 Why?
Nitric Oxide Synthase Type I
1
2014
28
0.110
 Why?
Thrombotic Microangiopathies
1
2014
20
0.110
 Why?
Echocardiography, Stress
1
2013
25
0.110
 Why?
Tumor Lysis Syndrome
1
2013
8
0.110
 Why?
Ribosomal Proteins
1
2014
93
0.110
 Why?
MAP Kinase Kinase Kinase 5
1
2013
6
0.110
 Why?
Mice, Transgenic
5
2020
2167
0.110
 Why?
Autografts
1
2013
44
0.110
 Why?
Transcription Factors
2
2019
1719
0.110
 Why?
Thioredoxins
1
2013
30
0.100
 Why?
Policy Making
1
2014
98
0.100
 Why?
HLA-DR4 Antigen
1
2013
78
0.100
 Why?
Testis
1
2014
151
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1081
0.100
 Why?
Extremities
1
2014
131
0.100
 Why?
Motor Skills
1
2014
97
0.100
 Why?
Cross-Sectional Studies
5
2017
5472
0.100
 Why?
Health Care Reform
1
2014
107
0.100
 Why?
Cognition
2
2023
1153
0.100
 Why?
Allografts
1
2013
146
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
283
0.100
 Why?
Immunoglobulin G
1
2017
893
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
547
0.100
 Why?
Astrocytoma
1
2013
128
0.100
 Why?
Transcriptional Activation
1
2015
378
0.100
 Why?
Interferon-alpha
1
2014
198
0.100
 Why?
Cell Movement
4
2019
967
0.100
 Why?
Histones
1
2018
636
0.100
 Why?
Nuclear Proteins
2
2015
712
0.100
 Why?
Radiation Injuries
1
2014
145
0.100
 Why?
Likelihood Functions
1
2013
144
0.100
 Why?
Nanotechnology
1
2013
125
0.100
 Why?
Infant, Newborn
4
2023
6079
0.100
 Why?
Esophageal Neoplasms
1
2016
321
0.100
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
233
0.100
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
219
0.090
 Why?
Survival Rate
4
2020
1972
0.090
 Why?
Risk Factors
5
2023
10388
0.090
 Why?
Calcinosis
1
2014
235
0.090
 Why?
Muscle Proteins
1
2013
231
0.090
 Why?
Sarcoma
1
2014
188
0.090
 Why?
Propensity Score
1
2013
294
0.090
 Why?
Cost of Illness
1
2014
308
0.090
 Why?
Risk Assessment
3
2019
3457
0.090
 Why?
Killer Cells, Natural
1
2014
449
0.090
 Why?
Prostatic Neoplasms
1
2019
1043
0.090
 Why?
Randomized Controlled Trials as Topic
2
2013
1477
0.090
 Why?
Anxiety
1
2018
1035
0.090
 Why?
Genome, Human
1
2013
425
0.090
 Why?
Research Design
2
2014
1139
0.090
 Why?
Wounds and Injuries
1
2018
758
0.090
 Why?
Health Policy
1
2014
388
0.090
 Why?
Cytotoxicity, Immunologic
3
2016
224
0.090
 Why?
Xenograft Model Antitumor Assays
3
2020
872
0.080
 Why?
Head and Neck Neoplasms
1
2016
606
0.080
 Why?
RNA-Binding Proteins
1
2014
422
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
976
0.080
 Why?
Genetic Testing
1
2013
460
0.080
 Why?
Decision Support Techniques
1
2013
421
0.080
 Why?
K562 Cells
2
2020
89
0.080
 Why?
Time Factors
2
2017
6828
0.080
 Why?
Models, Theoretical
1
2013
578
0.080
 Why?
HIV-1
1
2015
864
0.080
 Why?
Real-Time Polymerase Chain Reaction
3
2015
346
0.080
 Why?
Databases, Factual
3
2023
1357
0.070
 Why?
Adenocarcinoma
1
2016
940
0.070
 Why?
Colorado
2
2017
4565
0.070
 Why?
Protein Kinase Inhibitors
1
2014
916
0.070
 Why?
Coronary Stenosis
1
2008
38
0.070
 Why?
Anti-HIV Agents
1
2015
778
0.070
 Why?
Comorbidity
3
2018
1622
0.070
 Why?
RNA
1
2015
921
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1167
0.070
 Why?
Double-Blind Method
1
2013
1993
0.070
 Why?
Apoptosis
2
2013
2553
0.070
 Why?
Neoplasm Transplantation
3
2015
257
0.070
 Why?
Neutrophils
1
2013
1238
0.070
 Why?
RNA, Small Interfering
3
2014
622
0.070
 Why?
Protective Factors
2
2017
93
0.070
 Why?
Faculty
1
2007
147
0.060
 Why?
Mass Screening
2
2020
1287
0.060
 Why?
Cross Reactions
2
2016
133
0.060
 Why?
DNA Mutational Analysis
2
2019
399
0.060
 Why?
Molecular Sequence Data
3
2015
2900
0.060
 Why?
Cardiovascular Diseases
1
2018
2111
0.060
 Why?
CD4 Antigens
2
2016
141
0.060
 Why?
Neutropenia
2
2017
146
0.060
 Why?
Mice, Inbred C57BL
4
2020
5757
0.060
 Why?
Mice, Inbred NOD
2
2018
601
0.060
 Why?
Retrospective Studies
5
2024
15657
0.060
 Why?
Single-Chain Antibodies
2
2015
18
0.060
 Why?
Protein Transport
2
2017
445
0.060
 Why?
Intercellular Junctions
2
2014
40
0.050
 Why?
Physical Examination
2
2017
241
0.050
 Why?
GPI-Linked Proteins
2
2014
73
0.050
 Why?
Parity
1
2024
126
0.050
 Why?
Lung
1
2016
4060
0.050
 Why?
Nerve Tissue Proteins
2
2020
596
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
27
0.050
 Why?
Exercise
1
2015
2057
0.050
 Why?
Point Mutation
2
2014
235
0.050
 Why?
Health Facilities
1
2023
84
0.050
 Why?
Autoantigens
2
2016
430
0.050
 Why?
Bone Marrow
1
2023
286
0.050
 Why?
Minority Groups
1
2024
266
0.050
 Why?
Receptors, Cell Surface
1
2004
385
0.050
 Why?
Cluster Analysis
2
2014
499
0.050
 Why?
Linear Models
1
2024
849
0.050
 Why?
Skin
2
2019
752
0.050
 Why?
Alleles
2
2015
891
0.050
 Why?
Severity of Illness Index
2
2023
2828
0.040
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
767
0.040
 Why?
Educational Status
1
2023
470
0.040
 Why?
Recombinant Proteins
2
2014
1353
0.040
 Why?
Proportional Hazards Models
1
2024
1266
0.040
 Why?
Parenting
1
2024
310
0.040
 Why?
Models, Genetic
2
2013
600
0.040
 Why?
Jurkat Cells
1
2020
134
0.040
 Why?
Predictive Value of Tests
2
2017
2031
0.040
 Why?
Base Sequence
2
2014
2181
0.040
 Why?
Immunoglobulins
1
2020
171
0.040
 Why?
Cysteine Endopeptidases
1
2020
73
0.040
 Why?
Glioma
1
2004
395
0.040
 Why?
Early Diagnosis
1
2020
242
0.040
 Why?
Caregivers
2
2018
877
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
69
0.040
 Why?
Health Care Surveys
1
2021
565
0.040
 Why?
Hydrolysis
1
2019
177
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
3
0.040
 Why?
GTP Phosphohydrolases
1
2019
93
0.040
 Why?
Protein Domains
1
2020
289
0.040
 Why?
Cervix Uteri
1
2018
48
0.040
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
17
0.040
 Why?
Forests
1
2018
62
0.040
 Why?
Nuclear Localization Signals
1
2017
18
0.040
 Why?
Neoplasm Grading
1
2019
307
0.030
 Why?
Uterine Cervical Dysplasia
1
2018
42
0.030
 Why?
Mice, SCID
1
2018
367
0.030
 Why?
Hydrogen Bonding
1
2018
163
0.030
 Why?
Healthcare Disparities
1
2024
654
0.030
 Why?
Disulfides
1
2018
107
0.030
 Why?
Platelet Aggregation
1
2018
103
0.030
 Why?
Eye Enucleation
1
2017
12
0.030
 Why?
Human papillomavirus 18
1
2017
16
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
18
0.030
 Why?
Ligands
2
2013
664
0.030
 Why?
Protein Stability
1
2018
176
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
16
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
20
0.030
 Why?
Culture Media, Serum-Free
1
2016
48
0.030
 Why?
Lymphopenia
1
2017
62
0.030
 Why?
Peptide Fragments
2
2015
706
0.030
 Why?
Vaccinia virus
1
2016
43
0.030
 Why?
Binding Sites
1
2020
1303
0.030
 Why?
Drug Synergism
1
2017
382
0.030
 Why?
Antigen-Presenting Cells
1
2017
156
0.030
 Why?
HLA-DRB1 Chains
1
2017
112
0.030
 Why?
Blood Chemical Analysis
1
2017
99
0.030
 Why?
Adenosine Triphosphate
1
2019
491
0.030
 Why?
Salivary Glands, Minor
1
2016
11
0.030
 Why?
Asymptomatic Diseases
1
2017
89
0.030
 Why?
Tissue Array Analysis
1
2016
57
0.030
 Why?
Health Surveys
1
2018
514
0.030
 Why?
Cell Membrane
1
2020
738
0.030
 Why?
Radiotherapy
1
2017
201
0.030
 Why?
Neoplasm Invasiveness
1
2018
510
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Fas Ligand Protein
1
2015
60
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Palate
1
2016
38
0.030
 Why?
Antigen-Antibody Reactions
1
2015
55
0.030
 Why?
Machine Learning
1
2021
493
0.030
 Why?
Feasibility Studies
1
2020
956
0.030
 Why?
Genes, erbB-2
1
2015
28
0.030
 Why?
Salvage Therapy
1
2016
142
0.030
 Why?
MAP Kinase Signaling System
1
2017
320
0.030
 Why?
Health Promotion
1
2022
741
0.030
 Why?
Anemia
1
2017
170
0.030
 Why?
Interferon-gamma Release Tests
1
2015
32
0.030
 Why?
Anus Neoplasms
1
2015
33
0.030
 Why?
Compulsive Behavior
1
2015
6
0.030
 Why?
Thrombocytopenia
1
2017
200
0.030
 Why?
Necrosis
1
2016
246
0.030
 Why?
DNA, Neoplasm
1
2015
164
0.030
 Why?
Coronary Occlusion
1
2015
19
0.030
 Why?
Cloning, Molecular
1
2016
534
0.030
 Why?
HIV Envelope Protein gp120
1
2015
60
0.030
 Why?
Gastrointestinal Diseases
1
2017
209
0.030
 Why?
Dermatitis
1
2014
20
0.030
 Why?
HIV Antibodies
1
2015
62
0.030
 Why?
Metabolic Clearance Rate
1
2014
115
0.030
 Why?
Desmoplakins
1
2014
20
0.030
 Why?
Income
1
2016
202
0.030
 Why?
Regression Analysis
1
2017
1024
0.030
 Why?
Protein Conformation
1
2018
934
0.030
 Why?
Transplantation, Homologous
1
2016
416
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
152
0.030
 Why?
Monophenol Monooxygenase
1
2014
8
0.030
 Why?
Comparative Genomic Hybridization
1
2014
30
0.030
 Why?
Cell Survival
1
2017
1120
0.030
 Why?
Nausea
1
2014
111
0.030
 Why?
Models, Statistical
1
2018
669
0.030
 Why?
Gene Library
1
2014
118
0.030
 Why?
Mice, Inbred BALB C
1
2017
1272
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
128
0.030
 Why?
Random Allocation
1
2014
353
0.030
 Why?
MAP Kinase Kinase 4
1
2013
29
0.030
 Why?
Histocompatibility Antigens
1
2014
105
0.030
 Why?
Substrate Specificity
1
2014
372
0.030
 Why?
Infusions, Intravenous
1
2014
413
0.030
 Why?
Sleep Wake Disorders
1
2017
286
0.030
 Why?
Social Class
1
2016
282
0.030
 Why?
Graft vs Host Disease
1
2016
252
0.030
 Why?
Radiotherapy, Adjuvant
1
2014
220
0.030
 Why?
Lentivirus
1
2013
56
0.030
 Why?
X-Ray Diffraction
1
2013
104
0.030
 Why?
Tumor Burden
1
2014
309
0.030
 Why?
Confidence Intervals
1
2014
329
0.030
 Why?
Immunoenzyme Techniques
1
2013
219
0.030
 Why?
Immunoprecipitation
1
2013
155
0.030
 Why?
Fever
1
2014
306
0.030
 Why?
Structure-Activity Relationship
1
2014
570
0.030
 Why?
Health Services Accessibility
1
2021
986
0.030
 Why?
Reproducibility of Results
2
2012
3284
0.020
 Why?
Drug Administration Schedule
1
2014
786
0.020
 Why?
Models, Molecular
1
2018
1570
0.020
 Why?
Cotinine
1
2012
77
0.020
 Why?
Bias
1
2013
218
0.020
 Why?
Cost-Benefit Analysis
1
1995
591
0.020
 Why?
DNA Primers
1
2013
515
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
367
0.020
 Why?
Receptors, Immunologic
1
2013
216
0.020
 Why?
Spleen
1
2014
514
0.020
 Why?
Bayes Theorem
1
2013
405
0.020
 Why?
Pregnancy
1
2023
6763
0.020
 Why?
Blotting, Western
1
2013
1226
0.020
 Why?
Liver Neoplasms
1
2017
786
0.020
 Why?
Diagnosis, Differential
1
2015
1483
0.020
 Why?
Multivariate Analysis
1
2014
1509
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2057
0.020
 Why?
Carrier Proteins
1
2014
771
0.020
 Why?
Kinetics
1
2013
1670
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1242
0.020
 Why?
Phosphorylation
1
2014
1759
0.020
 Why?
Infant, Premature
1
2014
574
0.020
 Why?
North Carolina
1
2008
110
0.020
 Why?
Germany
1
2008
121
0.020
 Why?
Self Report
1
2012
827
0.020
 Why?
Cell Differentiation
1
2015
1991
0.020
 Why?
Vaccination
1
2016
1381
0.020
 Why?
Disease Models, Animal
1
2018
4295
0.020
 Why?
Models, Biological
1
2014
1783
0.020
 Why?
Intelligence
1
2007
123
0.020
 Why?
MicroRNAs
1
2013
692
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2189
0.010
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
15
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
29
0.010
 Why?
Transplantation, Heterologous
1
2004
194
0.010
 Why?
Species Specificity
1
2004
585
0.010
 Why?
Neovascularization, Pathologic
1
2004
301
0.010
 Why?
Mice, Nude
1
2004
698
0.010
 Why?
Down Syndrome
1
1987
496
0.010
 Why?
Polyethylene Glycols
1
2004
641
0.010
 Why?
Endothelium, Vascular
1
2004
927
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (596) concept(s)
_
Co-Authors Expand Description
See all (11) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)